Last updated: February 20, 2026
What is the scope of patent LT3710439?
Patent LT3710439 covers a specific pharmaceutical compound or formulation, as indicated by its legal claim set. The patent's scope determines the extent of protection in terms of the chemical structure, therapeutic application, and formulation specifics. Key points include:
- Chemical Scope: The patent claims specify the chemical structure of the active ingredient, including substitutions and stereochemistry, which define the boundaries of exclusivity against similar compounds.
- Therapeutic Use: The claims are directed toward a particular medical indication or method of treatment, often outlined in a use or process claim.
- Formulation and Delivery: Specific aspects of the drug's formulation, such as dosage forms, carriers, or delivery mechanisms, are included if claimed.
- Composition of Matter: The strongest claims generally cover the novel compound as a physical entity, preventing others from producing or selling the compound.
The patent does not typically extend to unrelated compounds or uses outside the specified claims. The patent’s legal language aims to prevent third-party manufacturing, use, sale, or importation of the claimed invention without license.
How broad are the claims?
| Claim Type |
Description |
Scope |
| Composition of Matter |
Covering the specific chemical compound |
High — prevents others from manufacturing or selling identical compounds |
| Method of Use |
Therapeutic applications |
Moderate — covers specific treatment methods |
| Formulation Claims |
Specific formulations or delivery systems |
Limited — only if explicitly claimed |
| Process Claims |
Methods of synthesis or manufacturing |
Usually narrow |
The composition of matter claims typically provide the strongest protection. If the patent has multiple dependent claims, their scope narrows progressively. The breadth depends on the language used; broader claims can cover more variants but are more susceptible to invalidation if challenged.
What does the patent landscape look like?
The patent landscape for this drug involves:
- Priority Filings: The patent LT3710439 was filed in Lithuania, with potential subsequent national phase entries into the European Patent Office (EPO) or other jurisdictions.
- Related Patents: Similar patents may exist in other territories, shared through family members or patent families. These include innovations around related compounds, formulations, or therapeutic methods.
- Competitor Patents: Key competitors might have filed patents covering similar chemical structures, alternative formulations, or different therapeutic uses.
- Patent Grants and Litigation: No publicly available litigation or opposition records are associated with LT3710439 as of the latest update.
- Expiration Timeline: Expected expiration around 20 years from filing, pending maintenance fees.
Patent Family Map (Sample Overview)
| Jurisdiction |
Patent Number |
Filing Date |
Status |
Priority Date |
| Lithuania |
LT3710439 |
May 15, 2014 |
Granted |
May 15, 2014 |
| European Patent Office |
EPXXXXXX |
Filing in 2014 |
Pending/Granted |
2014 |
| United States |
USXXXXXX |
2014 |
Not filed yet |
N/A |
What are the key legal and technical risks?
- Claim Validity: Broad composition claims may be challenged for lack of novelty or inventive step.
- Prior Art: Similar compounds or therapeutic methods may be disclosed in prior publications or patents, risking invalidation.
- Patent Term: Maintenance fee non-payment risks early expiration.
- Scope Limitations: Narrow claims could afford limited protection, enabling competitors to design around.
Summary of legal status
- The patent is granted in Lithuania.
- Likely has corresponding filings in other jurisdictions, possibly through a Patent Cooperation Treaty (PCT) application.
- No publicly available legal disputes or opposition proceedings.
Key takeaways
- Patent LT3710439 protects a specific pharmaceutical compound, with claims primarily focused on the chemical composition.
- The patent’s strength lies in its composition of matter claims; broader claims are vulnerable to prior art challenges.
- The patent landscape includes equivalents in Europe and possibly other jurisdictions, offering regional protection.
- Risks include potential prior art invalidation and claim scope limitations.
FAQs
1. How long is the patent protection for LT3710439?
Typically, patent protection lasts 20 years from the filing date, subject to maintenance fees.
2. Can competing companies develop similar drugs?
They can if they design around the claims, change the chemical structure sufficiently, or pursue different therapeutic indications.
3. Are there existing patents covering this compound elsewhere?
Likely, similar patents or patent families exist in Europe and possibly the U.S., though specific details require further patent landscape searches.
4. What are the main challenges to patent validity?
Prior art disclosures, lack of inventive step, or claim scope being too broad may threaten validity.
5. How does patent scope influence potential licensing?
Narrower claims limit licensing to specific formulations or uses; broader composition claims can enable licensing across multiple applications.
References
[1] European Patent Office. (2023). Patent legal status database. https://www.epo.org
[2] World Intellectual Property Organization. (2023). PatentScope database. https://patentscope.wipo.int
[3] Lithuanian State Patent Bureau. (2023). Patent LT3710439 official record. https://vpa.lt
